Hedgie: This biotech stock is going to zero By: CNBC.com News May 07, 2015 at 12:34 PM EDT The hedge fund manager who has already made a killing betting against biotech company MannKind now says the stock will soon be worthless. Read More >> Related Stocks: Sanofi-Aventis S.A. ADR